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We tested the hypothesis that crossing two mouse models of fetal growth restriction (FGR) of differing
phenotype would induce more severe FGR than either model alone. Female endothelial nitric oxide
synthase knockout mice (eNOS/) were mated with placental-speciﬁc Igf2 knockout males (P0).
Resultant fetuses were no more growth restricted than those with P0 deletion alone. However, P0
deletion attenuated the reduced placental system A amino acid transporter activity previously observed
in eNOS/mice. Manipulating maternal and fetal genotypes provides a means to compare maternal and
fetal regulation of fetal growth.
 2012 Elsevier Ltd. Open access under CC BY license.1. Introduction
Fetal growth restriction (FGR), the fetus’ inability to achieve its
growth potential, affects 5e10% of pregnancies and increases the
risk of stillbirth and childhoodmorbidity and mortality [1]. A major
cause of FGR is uteroplacental insufﬁciency [2]. Numerous genetic
mouse models demonstrate FGR; we have characterized, in terms
of placental structure/function, mice lacking the paternally-
imprinted placental-speciﬁc Igf2 promoter P0 (P0) [3,4], and the
endothelial nitric oxide synthase knockout mouse (eNOS/) [5].
Near term, >90% of P0 fetuses fall below the 5th centile of wild-
type (WT) weights, indicative of FGR [6]. P0 mice exhibit reduced
placental size from embryonic day (E) 14, prior to onset of FGR [3].
This ‘delay’ in FGRmay be achieved, in part, by an adaptive increase
in placental system A amino acid transport [3]. P0 placentas have
reduced surface area for exchange and increased barrier thickness,
probably contributing to FGR [7], in common with human FGR [8].h Research Centre, School of
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aberrant uterine artery function and reduced placental system A
transport [5], features characteristic of human FGR [10,11].
We tested the hypothesis that crossing these two disparate
placental phenotypes would result in greater FGR than either
model alone.2. Methods
2.1. Animals
Experiments were performed in accordance with the UK Animals (Scientiﬁc
Procedures) Act 1986. P0 mice were a kind gift from Professor W. Reik and Dr
M.Constância, University of Cambridge [12]. eNOS/ mice were obtained from
Jackson Laboratories (strain B6.129P2-Nos3tm1Unc/J).
eNOS/ female mice (8e12 weeks old) and P0 heterozygous males (8e32
weeks old) were mated; copulation plug discovery was designated E0.5
(term ¼ E19.5). All fetuses were eNOSþ/ with either the presence (eNOSþ/WT) or
absence (eNOSþ/ P0) of P0. C57BL/6J mice (background strain) acted as controls.
Animals were housed under a 12h light/dark cycle at 21e23 C with food (Beekay
Mouse Diet, Bantin & Kingman, Hull, UK) and water ad libitum. At E18.5, fetuses and
placentas were rapidly harvested from pregnant dams, blotted and wet weights
measured. Fetuses were genotyped for eNOS and P0 alleles using genomic DNA from
fetal tail tips [4,5].2.2. Unidirectional maternofetal clearance of MeAIB (MeAIBKmf) across the intact
placenta
MeAIBKmf across the intact placenta, a measure of system A amino acid transport,
was measured at E18.5 as described previously [3,4,13].
Fig. 1. Unidirectional maternofetal transport of MeAIB (MeAIBKmf) in eNOSþ/ WT,
eNOSþ/ P0 and C57BL/6J mice at E18.5. Each symbol corresponds to a mean
measurement per genotype per litter. Line denotes median. *P < 0.05, Kruskal Wallis
with Dunn’s multiple comparison test.
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Data aremean S.E.M or dot plots withmedian;N¼ number of litters. Variables
were compared using either one-way ANOVA or KruskaleWallis test as appropriate.
P < 0.05 was deemed statistically signiﬁcant.
3. Results and discussion
eNOSþ/ P0 fetal weights (Table 1) were signiﬁcantly less than
C57BL/6J and eNOSþ/WT. eNOSþ/ P0 mice, exposed to the dam’s
eNOS-deﬁcient environment, failed to demonstrate any further FGR
compared with P0 mice (Table 1) [3,4,6]. In contrast with eNOS/
mice [5,9], eNOSþ/ WT fetuses were of comparable weight to
C57BL/6J controls. Since eNOSþ/ WT fetuses are heterozygous for
eNOS, fetal eNOS expression, albeit at reduced levels [14], may
facilitate maintenance of fetal weight. This notion is reinforced by
data showing that eNOS/ mice fail to show postnatal catch-up
growth suggesting that complete deletion of eNOS leads to
comparably small mice both pre- and post-natally [14]. Previous
data from ourselves suggested that the growth restriction observed
in eNOS/ mice was likely due to placental insufﬁciency [5].
Evidence from the current study would appear to challenge our
previous observations on eNOS/ mice and demonstrates that
there could be a fetal contribution to the growth restriction. By
crossing these strains, we have manipulated maternal and fetal
genotype in such a way to allow assessment of maternal and/or
fetal contributions to fetal growth. Future crosses to compare
eNOSþ/ versus eNOS/ pupswithin the same litter may be helpful
in further determinations of these relative contributions.
Placental weight was reduced in eNOSþ/ P0 vs. eNOSþ/ WT
and C57BL/6J mice (Table 1), with no difference between C57BL/6J
and eNOSþ/ WT. Placental weight reduction in eNOSþ/ P0 mice
was similar to that observed previously in P0 mice [3,4]. Given that
eNOS/ placentas are of comparable size to WT [5,9], this reduc-
tion in eNOSþ/ P0 placental size is likely due to P0 deletion alone.
Fetal:placental (F:P) weight ratios, a marker of placental efﬁciency
[15,16], did not differ between groups (Table 1). This lack of
increased F:P ratio in eNOSþ/ P0 mice, seen previously in P0 mice
[3,4], is likely due to eNOS deletion and reﬂects a ‘half-way house’
between the increased and decreased efﬁciencies of the P0 [3,4]
and eNOS/ placentas [5,9] respectively.
At E18.5, MeAIBKmf, per gram of placenta, was signiﬁcantly lower
in eNOSþ/ WT vs. C57BL/6J mice (Fig. 1). This difference was not
observed between eNOSþ/ P0 and C57BL/6J nor between eNOSþ/
P0 and eNOSþ/ WT. Therefore the reduced placental system A
activity in eNOSþ/ WT mice, previously seen in eNOS/ mice
[5,9], was attenuated with P0 deletion. Interestingly, given that
reduced system A transport has been observed in both eNOSþ/WTTable 1
Fetal weight, placental weight and fetal:placental weight ratios of C57BL/6J, eNOSþ/
WT and eNOSþ/ P0 mice. Historical observations from eNOS/ (unpublished
observations from Dilworth and Kusinski) and P0 mice (taken from Ref. [4]) are
shown for comparison.
C57Bl/6J
(12)
eNOSþ/ WT
(8)
eNOSþ/ P0
(8)
eNOS/
(10)
P0
(16)
Fetal
weight
(mg)
1225  15 1173  38 918  26a,b 1064  19 926  16
Placental
weight
(mg)
84  3 90  1 65  1a,b 85  6 62  2
F:P ratio 14.7  0.4 13.2  0.4 14.4  0.5 13.0  0.8 15.2  0.5
All data mean  S.E.M. Number of litters used in parentheses.
a P < 0.001 versus C57BL/6J.
b P < 0.01 versus eNOSþ/ WT, One-way ANOVA with Tukey’s multiple compar-
ison test.and eNOS/ mice, but FGR is observed in eNOS/ only, it is
possible that reduced system A transport is not necessarily a direct
cause of FGR in eNOS/ mice as previously thought [5].
Our data again emphasise the importance of P0 in fetal growth
and suggest that abnormal morphology and transport of P0
placentas plays an important role in the observed FGR in these
mice. This model, through differing maternal and fetal genetic
manipulations, has provided new data suggesting that in eNOS/
mice, fetal genotype may be a key determinant of fetal growth.
Elucidating the role of maternal and fetal genetic manipulations in
their contributions to fetal growth will be crucial to ensure future
models of pregnancy disease are appropriate to the human situa-
tion. In the future, crossing mice with different uteroplacental
structural and functional characteristics may generate models that
recreate the multiple placental phenotypes of human FGR [17] and
may beneﬁt future studies both to determine disease mechanism
and to test potential therapies.
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